{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:24:59Z","timestamp":1740115499553,"version":"3.37.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011093","name":"University of Phayao","doi-asserted-by":"publisher","award":["FF64-UoE039"],"award-info":[{"award-number":["FF64-UoE039"]}],"id":[{"id":"10.13039\/501100011093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Gerontology and Geriatrics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.archger.2024.105727","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T20:48:40Z","timestamp":1734382120000},"page":"105727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patterns, determinants, and outcomes of early use of antidementia drugs: A 6-year multicenter cohort study in Thailand"],"prefix":"10.1016","volume":"130","author":[{"given":"Sirayut","family":"Phatthanasobhon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noppaket","family":"Singkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat","family":"Na-Ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuttana","family":"Wongsalap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Watchara","family":"Rattanachaisit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaowaret","family":"Mekkhayai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittipong","family":"Onseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roungtiva","family":"Muenpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimsai","family":"Chindasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyarat","family":"Winitkulchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-1557","authenticated-orcid":false,"given":"Pajaree","family":"Mongkhon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.archger.2024.105727_bib0046","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12031-009-9236-1","article-title":"Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: Role of alpha4 and alpha7 receptors in neuroprotection","volume":"40","author":"Akaike","year":"2010","journal-title":"Journal of Molecular Neuroscience : MN"},{"key":"10.1016\/j.archger.2024.105727_bib0018","unstructured":"Alzheimer\u2019s Disease International & Alzheimer's Australia. Dementia in the Asia Pacific Region 2014. Available from: https:\/\/www.alzint.org\/u\/Dementia-Asia-Pacific-2014.pdf."},{"issue":"1","key":"10.1016\/j.archger.2024.105727_bib0028","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40120-017-0067-7","article-title":"A real-world analysis of treatment patterns for cholinesterase inhibitors and memantine among newly-diagnosed Alzheimer's disease patients","volume":"6","author":"Bent-Ennakhil","year":"2017","journal-title":"Neurology and Therapy"},{"issue":"13","key":"10.1016\/j.archger.2024.105727_bib0043","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2165\/00023210-200317130-00002","article-title":"Clinically significant drug interactions with cholinesterase inhibitors: A guide for neurologists","volume":"17","author":"Bentu\u00e9-Ferrer","year":"2003","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.archger.2024.105727_bib0005","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1016\/j.archger.2024.105727_bib0042","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"Journal of the American Geriatrics Society"},{"issue":"1","key":"10.1016\/j.archger.2024.105727_bib0011","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1038\/s41598-022-08595-1","article-title":"Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM","volume":"12","author":"Byun","year":"2022","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.archger.2024.105727_bib0032","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40266-017-0446-x","article-title":"Trends in the prescription and long-term utilization of antidementia drugs among patients with Alzheimer's disease in Spain: A cohort study using the registry of dementias of Girona","volume":"34","author":"Calv\u00f3-Perxas","year":"2017","journal-title":"Drugs & Aging"},{"issue":"11","key":"10.1016\/j.archger.2024.105727_bib0027","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1016\/j.archger.2024.105727_bib0023","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000509731","article-title":"Characteristics and real-life outcomes of dementia and cognitive impairment at a geriatric clinic","volume":"49","author":"Chulakadabba","year":"2020","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"year":"2021","series-title":"Situation of the Thai older persons 2020","key":"10.1016\/j.archger.2024.105727_bib0016"},{"issue":"3","key":"10.1016\/j.archger.2024.105727_bib0020","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3233\/JAD-201502","article-title":"Early start of anti-dementia medication delays transition to 24-hour care in Alzheimer's disease patients: A Finnish nationwide cohort study","volume":"81","author":"Halminen","year":"2021","journal-title":"Journal of Alzheimer's Disease: JAD"},{"issue":"10","key":"10.1016\/j.archger.2024.105727_bib0031","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1532-5415.2007.01377.x","article-title":"A population-based study of cholinesterase inhibitor use for dementia","volume":"55","author":"Herrmann","year":"2007","journal-title":"Journal of the American Geriatrics Society"},{"issue":"1","key":"10.1016\/j.archger.2024.105727_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/YIC.0b013e3283339496","article-title":"Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany","volume":"25","author":"Hoffmann","year":"2010","journal-title":"International clinical psychopharmacology"},{"issue":"2","key":"10.1016\/j.archger.2024.105727_bib0038","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/01.WNL.0000129990.32253.7B","article-title":"The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease","volume":"63","author":"Holmes","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.archger.2024.105727_bib0008","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2377-11-99","article-title":"Prescribing patterns in dementia: A multicentre observational study in a German network of CAM physicians","volume":"11","author":"Jeschke","year":"2011","journal-title":"BMC Neurology"},{"issue":"8","key":"10.1016\/j.archger.2024.105727_bib0009","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/jgs.14226","article-title":"Treatment patterns with antidementia drugs in the United States: Medicare cohort study","volume":"64","author":"Koller","year":"2016","journal-title":"Journal of the American Geriatrics Society"},{"issue":"6","key":"10.1016\/j.archger.2024.105727_bib0033","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jval.2020.01.010","article-title":"Application of discrete-event simulation in health technology assessment: A cost-effectiveness analysis of Alzheimer's disease treatment using real-world evidence in Thailand","volume":"23","author":"Kongpakwattana","year":"2020","journal-title":"Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"issue":"1","key":"10.1016\/j.archger.2024.105727_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13696998.2018.1534739","article-title":"Compliance and persistence with Alzheimer's disease treatment: A retrospective analysis of multiregional hospital databases in Thailand","volume":"22","author":"Kongpakwattana","year":"2019","journal-title":"Journal of Medical Economics"},{"issue":"4","key":"10.1016\/j.archger.2024.105727_bib0019","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3233\/JAD-190288","article-title":"Impact of anti-dementia medication on the risk of death and causes of death in Alzheimer's disease","volume":"71","author":"Linna","year":"2019","journal-title":"Journal of Alzheimer's Disease: JAD"},{"issue":"12","key":"10.1016\/j.archger.2024.105727_bib0036","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/070674371405901203","article-title":"Persistence and adherence with dementia pharmacotherapy: Relevance of patient, provider, and system factors","volume":"59","author":"Maxwell","year":"2014","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"issue":"2","key":"10.1016\/j.archger.2024.105727_bib0006","article-title":"Memantine for dementia","author":"McShane","year":"2006","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.archger.2024.105727_bib0034","doi-asserted-by":"crossref","first-page":"451","DOI":"10.18553\/jmcp.2008.14.5.451","article-title":"Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease","volume":"14","author":"Mucha","year":"2008","journal-title":"Journal of Managed Care Pharmacy : JMCP"},{"year":"2018","series-title":"Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease: NICE","key":"10.1016\/j.archger.2024.105727_bib0004"},{"year":"2021","series-title":"Neurological Institute of Thailand","key":"10.1016\/j.archger.2024.105727_bib0040"},{"key":"10.1016\/j.archger.2024.105727_bib0017","series-title":"TDRI quarterly review. 38","first-page":"3","article-title":"Promotion of active aging and quality of life in old age and preparation for a complete aged society in Thailand","author":"Paitoonpong","year":"2023"},{"issue":"7","key":"10.1016\/j.archger.2024.105727_bib0007","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/pds.1613","article-title":"Prevalence of cholinesterase inhibitors in subjects with dementia in Europe","volume":"17","author":"Pariente","year":"2008","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"4","key":"10.1016\/j.archger.2024.105727_bib0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/0019-5545.58292","article-title":"Clinical practice with antidementia and antipsychotic drugs: Audit from a geriatric clinic in India","volume":"51","author":"Prasad","year":"2009","journal-title":"Indian Journal of Psychiatry"},{"year":"2011","series-title":"World Alzheimer report 2011 the benefits of early diagnosis and intervention","author":"Prince","key":"10.1016\/j.archger.2024.105727_bib0049"},{"year":"2015","series-title":"World Alzheimer report 2015. The global impact of dementia: An analysis of revalence, incidence, cost and trends","author":"Prince","key":"10.1016\/j.archger.2024.105727_bib0002"},{"issue":"Suppl 2(0 2)","key":"10.1016\/j.archger.2024.105727_bib0041","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.3233\/JAD-2011-110599","article-title":"Dyslipidemia and dementia: Current epidemiology, genetic evidence, and mechanisms behind the associations","volume":"30","author":"Reitz","year":"2012","journal-title":"Journal of Alzheimer's Disease: JAD"},{"issue":"2","key":"10.1016\/j.archger.2024.105727_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt7","article-title":"Persistent treatment with cholinesterase inhibitors and\/or memantine slows clinical progression of Alzheimer disease","volume":"1","author":"Rountree","year":"2009","journal-title":"Alzheimer's Research & Therapy"},{"issue":"3","key":"10.1016\/j.archger.2024.105727_bib0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jalz.2012.01.002","article-title":"Effectiveness of antidementia drugs in delaying Alzheimer's disease progression","volume":"9","author":"Rountree","year":"2013","journal-title":"Alzheimer's & Dementia"},{"issue":"8","key":"10.1016\/j.archger.2024.105727_bib0022","first-page":"1081","article-title":"Clinical practice with antidementia drugs in a geriatric clinic","volume":"95","author":"Rungsanpanya","year":"2012","journal-title":"Journal of the Medical Association of Thailand\u00a0=\u00a0Chotmaihet Thangphaet"},{"issue":"12","key":"10.1016\/j.archger.2024.105727_bib0047","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1001\/archneur.61.12.1852","article-title":"Efficacy of donepezil in early-stage Alzheimer disease: A randomized placebo-controlled trial","volume":"61","author":"Seltzer","year":"2004","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.archger.2024.105727_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/alz.061560","article-title":"Five year dementia registry in Thailand: Regional distribution, etiologies, and outcome of dementia","volume":"19","author":"Senanarong","year":"2023","journal-title":"Alzheimer's & Dementia"},{"issue":"Suppl 3","key":"10.1016\/j.archger.2024.105727_bib0003","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.4103\/0019-5545.224472","article-title":"Clinical practice guidelines for management of dementia","volume":"60","author":"Shaji","year":"2018","journal-title":"Indian journal of psychiatry"},{"issue":"20","key":"10.1016\/j.archger.2024.105727_bib0044","doi-asserted-by":"crossref","first-page":"e2313","DOI":"10.1212\/WNL.0000000000201161","article-title":"Effect of cholinesterase inhibitors on mortality in patients with dementia: A systematic review of randomized and nonrandomized trials","volume":"99","author":"Truong","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.archger.2024.105727_bib0029","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1017\/S1041610209991530","article-title":"Prescribing of drugs for Alzheimer's disease: A South African database analysis","volume":"22","author":"Truter","year":"2010","journal-title":"International Psychogeriatrics \/ IPA"},{"issue":"4","key":"10.1016\/j.archger.2024.105727_bib0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0891988718785775","article-title":"Prescription of antidementia drugs and antipsychotics for elderly patients in Japan: A descriptive study using pharmacy prescription data","volume":"31","author":"Tsukada","year":"2018","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"4","key":"10.1016\/j.archger.2024.105727_bib0013","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YIC.0b013e328344c600","article-title":"Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: Results of a claims data-based 1-year follow-up","volume":"26","author":"van den Bussche","year":"2011","journal-title":"International Clinical Psychopharmacology"},{"issue":"9","key":"10.1016\/j.archger.2024.105727_bib0021","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10198-022-01553-8","article-title":"Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer\u00b4s patients: A Finnish nationwide register study","volume":"24","author":"Vesikansa","year":"2023","journal-title":"The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care"},{"issue":"4","key":"10.1016\/j.archger.2024.105727_bib0024","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"year":"2022","series-title":"Structure and principles","key":"10.1016\/j.archger.2024.105727_bib0026"},{"issue":"1","key":"10.1016\/j.archger.2024.105727_bib0048","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/gps.1652","article-title":"Access to diagnostic evaluation and treatment for dementia in Europe","volume":"22","author":"Waldemar","year":"2007","journal-title":"International Journal of Geriatric Psychiatry"},{"year":"2017","series-title":"Global action plan on the public health response to dementia 2017-2025","key":"10.1016\/j.archger.2024.105727_bib0001"},{"year":"2019","series-title":"International statistical classification of diseases and related health problems 10th revision (ICD-10)","key":"10.1016\/j.archger.2024.105727_bib0025"},{"issue":"1","key":"10.1016\/j.archger.2024.105727_bib0039","doi-asserted-by":"crossref","first-page":"e12014","DOI":"10.1002\/trc2.12014","article-title":"Prescription patterns of antidementives in a high income country: A pharmacoepidemiologic study","volume":"6","author":"Wurm","year":"2020","journal-title":"Alzheimer's & Dementia : Translational Research & Clinical Interventions"},{"key":"10.1016\/j.archger.2024.105727_bib0014","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12913-015-0855-7","article-title":"Antidementia drug treatment in dementia networks in Germany: Use rates and factors associated with treatment use","volume":"15","author":"W\u00fcbbeler","year":"2015","journal-title":"BMC Health Services Research"},{"issue":"6","key":"10.1016\/j.archger.2024.105727_bib0012","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jamda.2021.07.017","article-title":"Prescription patterns of antidementia and psychotropic drugs in people living with dementia: Findings from the clinical pathway study of Alzheimer's disease in China","volume":"23","author":"Zhang","year":"2022","journal-title":"Journal of the American Medical Directors Association"}],"container-title":["Archives of Gerontology and Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494324004023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167494324004023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T19:10:40Z","timestamp":1736277040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167494324004023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"alternative-id":["S0167494324004023"],"URL":"https:\/\/doi.org\/10.1016\/j.archger.2024.105727","relation":{},"ISSN":["0167-4943"],"issn-type":[{"type":"print","value":"0167-4943"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns, determinants, and outcomes of early use of antidementia drugs: A 6-year multicenter cohort study in Thailand","name":"articletitle","label":"Article Title"},{"value":"Archives of Gerontology and Geriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archger.2024.105727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105727"}}